Modern Strategies for Hairy Cell Leukemia (Q37827275)

23 August 2017

1 reference

title

Modern strategies for hairy cell leukemia (English)

1 reference

23 August 2017

Modern Strategies for Hairy Cell Leukemia (English)

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

21 November 2024

1 reference

Gerard Lozanski

1 reference

23 August 2017

Michael R. Grever

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21220590

21 November 2024

language of work or name

English

0 references

publication date

10 January 2011

1 reference

full work available at URL

23 August 2017

http://intl.jco.org/cgi/content/abstract/29/5/583

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21220590

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.31.7016

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Journal of Clinical Oncology

21 November 2024

published in

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

583-590

1 reference

Alpha interferon for induction of remission in hairy-cell leukemia

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Hairy cell leukemia: treatment successes in the past 25 years

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin)

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Pentostatin in the treatment of advanced hairy cell leukemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Pentostatin in hairy cell leukemia: treatment by the special exception mechanism

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Extended follow-up of patients with hairy cell leukemia after treatment with cladribine

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Cladribine in the treatment of hairy cell leukemia: initial and subsequent results

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98).

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

How I treat hairy cell leukemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

21 November 2024

Lauria F

1999

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

21 November 2024

309

Zinzani PL

2004

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Long-term follow-up studies in hairy cell leukemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Clinical presentations and complications of hairy cell leukemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Risk factors for severe infection in patients with hairy cell leukemia: a long-term study of 73 patients

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Immunophenotyping and differential diagnosis of hairy cell leukemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Hairy-cell leukemia variant: recent view on diagnosis, biology and treatment

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Hairy cell leukemia: diagnostic pathology.

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Successful treatment of aplastic variant of hairy-cell leukaemia with deoxycoformycin

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxyadenosine therapy

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Clinical manifestations and infectious complications of hairy-cell leukaemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Therapeutic advances in the treatment of hairy cell leukemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Eradication of minimal residual disease in hairy cell leukemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

21 November 2024

1046

Lauria F

2001

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Monoclonal antibody therapy for hairy cell leukemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Bone marrow remission of hairy cell leukaemia induced by rituximab (anti-CD20 monoclonal antibody) in a patient refractory to cladribine

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia.

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Rituximab in relapsed or refractory hairy cell leukemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Rituximab as treatment for minimal residual disease in hairy cell leukaemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Approach to the patient after relapse of hairy cell leukemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case report

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011.

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Recombinant immunotoxins for the treatment of chemoresistant hematologic malignancies.

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

The microenvironment in mature B-cell malignancies: a target for new treatment strategies

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

The biology of hairy cell leukemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

The pathophysiology of the hairy cell

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Secondary acute myeloid leukemia 4 years after the diagnosis of hairy cell leukemia: case report and review of the literature

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Secondary acute myeloid leukemia following successful treatment of hairy cell leukemia with cladribine

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Myelodysplasia terminating in acute myeloid leukemia in a hairy cell leukemia patient treated with 2-deoxycoformycin

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

Acute myeloid leukemia following treatment with cladribine for hairy cell leukemia: a case report and review of the literature

21 November 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.7016

21 November 2024

Identifiers

1 reference

23 August 2017

1 reference